Amicogen, INC.

Home
Product
Last Updated:03-28 2024

Company profile

“Industrial Biotechnology” means bio-conversion of raw materials into industrially beneficial materials using enzymes or microorganisms. Amicogen always makes efforts to reduce consumption of energy, natural resource, emission of CO₂ and wastes by applying our specialty enzymes and microbes. A LEADER in global industrial biotechnology. We developed many innovative biocatalysts for pharmaceutical, food and feed industry by applying our proprietary i DNA Evolution™ Technology. For the first time, we successfully developed CPC Acylase (CA), 7-ACA synthesizing enzyme in the world, and tech-transferred to multinational pharmaceutical company in 2005. We have established our local and global business basis on the sincerity and trust in USA, Canada, China, Japan, and Europe for more than 14 years. Our passion to better health world inspires us and create new value for human health and nature. We will expand our business with our partners.

Main Sales Markets:North America，Central/South America，Western Europe，Eastern Europe，Australasia，Asia，Middle East，Africa	Registration number:.6138121213
Main Competitive Advantages:	Main Product Categories:Starch and Starch Derivatives
All Sales(USD):choose not to disclose	Main Customer Name:

company Snapshot

Year Established:2000
Total Number of Staff: less than 10 person

Business Type：Manufacturer
Main Sales Markets：North America，Central/South America，Western Europe，Eastern Europe，Australasia，Asia，Middle East，Africa

Address:64, Dongbu-Ru 1259BEON-Gil, Jinseong-Myeon, Jinju-Si, Gyeongsangnam-Do, South Korea

Contact:Minji Park
TEL:82 70-4266 9009
Fax:82 70-0086 537 326 1821/ 82 31 628 0980

Product Showcase